Sutro Biopharma, Inc. financial statements
Sutro Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 102.48M | 10-K |
| Net income | −USD 191.09M | 10-K |
| Cash and equivalents | USD 58.13M | 10-Q |
| Total debt | USD 15.67M | EODHD |
Sutro Biopharma, Inc. financials on 6ix · Sutro Biopharma, Inc. on 6ix